Please use this identifier to cite or link to this item: http://cmuir.cmu.ac.th/jspui/handle/6653943832/910
Title: High virologic response rate after second-line boosted protease inhibitor-based antiretroviral therapy regimens in children from a resource limited setting
Authors: Puthanakit T.
Jourdain G.
Suntarattiwong P.
Chokephaibulkit K.
Siangphoe U.
Suwanlerk T.
Prasitsuebsai W.
Sirisanthana V.
Kosalaraksa P.
Petdachai W.
Hansudewechakul R.
Waranawat N.
Ananworanich J.
Bunupuradah T.
Phasomsap C.
Kaew-on P.
Kanjanavanit S.
Hinjiranandana T.
Layangool P.
Kamonpakorn N.
Buranabanjasatean S.
Ngampiyaskul C.
Chotpitayasunondh T.
Chanpradub S.
Leawsrisuk P.
Chearskul S.
Vanprapar N.
Phongsamart W.
Lapphra K.
Chearskul P.
Wittawatmongkol O.
Intalapaporn K.
Kongstan N.
Pannin N.
Maleesatharn A.
Khumcha B.
Aurpibul L.
Wongnum N.
Nadsasarn R.
Lumbiganon P.
Tharnprisan P.
Udompanich T.
Yentang M.
Khonponoi A.
Maneerat N.
Denjunta S.
WatanapornS.
Yodsuwan C.
Srisuk W.
Somsri S.
Surapanichadul K.
Issue Date: 2012
Abstract: Background: Limited data exist for the efficacy of second-line antiretroviral therapy among children in resource limited settings. We assessed the virologic response to protease inhibitor-based ART after failing first-line non-nucleoside reverse transcriptase inhibitor (NNRTI)-based regimens.Methods: A retrospective chart review was conducted at 8 Thai sites of children who switched to PI -based regimens due to failure of NNRTI -based regimens. Primary endpoints were HIV RNA < 400 copies/ml and CD4 change over 48 weeks.Results: Data from 241 children with median baseline values before starting PI-based regimens of 9.1 years for age, 10% for CD4%, and 4.8 log 10 copies/ml for HIV RNA were included; 104 (41%) received a single ritonavir-boosted PI (sbPI) with 2 NRTIs and 137 (59%) received double-boosted PI (dbPI) with/without NRTIs based on physician discretion. SbPI children had higher baseline CD4 (17% vs. 6%, p < 0.001), lower HIV RNA (4.5 vs. 4.9 log 10 copies/ml, p < 0.001), and less frequent high grade multi-NRTI resistance (12.4% vs 60.5%, p < 0.001) than the dbPI children. At week 48, 81% had HIV RNA < 400 copies/ml (sbPI 83.1% vs. dbPI 79.8%, p = 0.61) with a median CD4 rise of 9% (+7%vs. + 10%, p < 0.005). However, only 63% had HIV RNA < 50 copies/ml, with better viral suppression seen in sbPI (76.6% vs. 51.4%, p 0.002).Conclusion: Second-line PI therapy was effective for children failing first line NNRTI in a resource-limited setting. DbPI were used in patients with extensive drug resistance due to limited treatment options. Better access to antiretroviral drugs is needed. © 2012 Puthanakit et al.; licensee BioMed Central Ltd.
URI: http://www.scopus.com/inward/record.url?eid=2-s2.0-84862259247&partnerID=40&md5=6ff3b2a6f81229cd5af4814071687000
http://cmuir.cmu.ac.th/handle/6653943832/910
ISSN: 17426405
Appears in Collections:AMS: Journal Articles

Files in This Item:
There are no files associated with this item.


Items in CMUIR are protected by copyright, with all rights reserved, unless otherwise indicated.